In melanoma cells, the histone methyltransferase KMT2D, which can methylate Lys-4 in histone 3, has been found to keep proximal and distal IGFBP5-regulating enhancers in an open state, thereby contributing to high IGFBP5 levels (172). Here, KMT2D is linked to melanoma.